Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
The American Journal of Gastroenterology
|
April 1, 1993
Ranitidine is effective therapy for erosive esophagitis
A R Euler, R H Murdock, T H Wilson, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
April 1, 1990
Gastric emptying and the pharmacokinetics of the cephalosporin antibiotic, cefpodoxime proxetil
G S Hughes, D L Heald, R Patel, et al.
Acta Paediatrica (Oslo, Norway : 1992)
|
September 30, 1999
Assessment of feeding different amounts of arachidonic and docosahexaenoic acids in preterm infant formulas on the fatty acid content of lipoprotein lipids
M T Clandinin, J E Van Aerde, A Parrott, et al.
Gastroenterology
|
March 1, 1987
Failure of a cytoprotective dose of arbaprostil to heal acute duodenal ulcers. Results of a multiclinic trial
A R Euler, G Tytgat, J Berenguer, et al.
Journal of Clinical Pharmacology
|
November 1, 1987
The effect of itazigrel and aspirin on the mucosa of the esophagus, stomach, and duodenum of normal subjects
D M Demke, J R Luderer, L K Wakefield, et al.
Pediatric Research
|
December 13, 1997
Assessment of the efficacious dose of arachidonic and docosahexaenoic acids in preterm infant formulas: fatty acid composition of erythrocyte membrane lipids
M T Clandinin, J E Van Aerde, A Parrott, et al.
Gastroenterology
|
April 1, 1989
A multiclinic trial evaluating arbaprostil [15(R)-15-methyl prostaglandin E2] as a therapeutic agent for gastric ulcer
A R Euler, T Popiela, G N Tytgat, et al.
Annals of Nutrition & Metabolism
|
June 6, 2000
Growth in human milk-Fed very low birth weight infants receiving a new human milk fortifier
P Porcelli, R Schanler, F Greer, et al.
Gastroenterology
|
June 1, 1990
A report of three multiclinic trials evaluating arbaprostil in arthritic patients with ASA/NSAID gastric mucosal damage. The Upjohn Company Arbaprostil ASA/NSAID Gastric Mucosal Damage Treatment Study Groups
A R Euler, M Safdi, J Rao, et al.
The American Journal of Gastroenterology
|
February 1, 1990
An evaluation of arbaprostil at multiple doses for the treatment of acute duodenal ulcer: a randomized double-blind placebo-controlled international trial
A R Euler, J Krawiec, H Odes, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
The American Journal of Gastroenterology
|
April 1, 1993
Ranitidine is effective therapy for erosive esophagitis
A R Euler, R H Murdock, T H Wilson, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
April 1, 1990
Gastric emptying and the pharmacokinetics of the cephalosporin antibiotic, cefpodoxime proxetil
G S Hughes, D L Heald, R Patel, et al.
Acta Paediatrica (Oslo, Norway : 1992)
|
September 30, 1999
Assessment of feeding different amounts of arachidonic and docosahexaenoic acids in preterm infant formulas on the fatty acid content of lipoprotein lipids
M T Clandinin, J E Van Aerde, A Parrott, et al.
Gastroenterology
|
March 1, 1987
Failure of a cytoprotective dose of arbaprostil to heal acute duodenal ulcers. Results of a multiclinic trial
A R Euler, G Tytgat, J Berenguer, et al.
Journal of Clinical Pharmacology
|
November 1, 1987
The effect of itazigrel and aspirin on the mucosa of the esophagus, stomach, and duodenum of normal subjects
D M Demke, J R Luderer, L K Wakefield, et al.
Pediatric Research
|
December 13, 1997
Assessment of the efficacious dose of arachidonic and docosahexaenoic acids in preterm infant formulas: fatty acid composition of erythrocyte membrane lipids
M T Clandinin, J E Van Aerde, A Parrott, et al.
Gastroenterology
|
April 1, 1989
A multiclinic trial evaluating arbaprostil [15(R)-15-methyl prostaglandin E2] as a therapeutic agent for gastric ulcer
A R Euler, T Popiela, G N Tytgat, et al.
Annals of Nutrition & Metabolism
|
June 6, 2000
Growth in human milk-Fed very low birth weight infants receiving a new human milk fortifier
P Porcelli, R Schanler, F Greer, et al.
Gastroenterology
|
June 1, 1990
A report of three multiclinic trials evaluating arbaprostil in arthritic patients with ASA/NSAID gastric mucosal damage. The Upjohn Company Arbaprostil ASA/NSAID Gastric Mucosal Damage Treatment Study Groups
A R Euler, M Safdi, J Rao, et al.
The American Journal of Gastroenterology
|
February 1, 1990
An evaluation of arbaprostil at multiple doses for the treatment of acute duodenal ulcer: a randomized double-blind placebo-controlled international trial
A R Euler, J Krawiec, H Odes, et al.
Page
of 6